Published in J Pediatr on April 01, 1997
Safety and immunogenicity of a fully liquid vaccine containing five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus influenzae type b conjugate vaccines administered at two, four, six and 18 months of age. Can J Infect Dis Med Microbiol (2007) 0.81
Ever-changing world of pediatric vaccines: why are we giving more shots? J Pediatr (1997) 0.75
Codon usage can affect efficiency of translation of genes in Escherichia coli. Nucleic Acids Res (1984) 4.51
Gastric cancer in Wales. Gut (1966) 2.31
The use of the surname as a genetic marker in Wales. J Med Genet (1966) 2.15
Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics (2000) 1.91
Competitive brain activity in visual attention. Curr Opin Neurobiol (1997) 1.84
Canadian Acute Respiratory Illness and Flu Scale (CARIFS): development of a valid measure for childhood respiratory infections. J Clin Epidemiol (2000) 1.82
Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology (2000) 1.76
Cancer of the lung. Histology and biological behavior. Cancer (1967) 1.58
Systematic analysis of deficits in visual attention. J Exp Psychol Gen (1999) 1.50
Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. Pediatrics (1997) 1.43
Beyond the search surface: visual search and attentional engagement. J Exp Psychol Hum Percept Perform (1992) 1.34
Inactivated poliovirus vaccine: past and present experience. Vaccine (1996) 1.22
Bloodstream infection-associated sepsis and septic shock in critically ill adults: a population-based study. Infection (2004) 1.18
A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection. Pediatrics (1999) 1.14
The pathology of rotavirus-associated deaths, using new molecular diagnostics. Clin Infect Dis (2003) 1.10
Experimental respiratory infection with Bordetella pertussis in mice: comparison of two methods. Clin Invest Med (1988) 1.09
Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program. Am J Public Health (1998) 1.08
Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr Infect Dis J (1994) 1.07
An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine (2000) 1.05
Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children. CMAJ (1991) 1.04
Strength and function in the normal and rheumatoid hand. J Rheumatol (1991) 1.00
Measles vaccination of infants in a well-vaccinated population. Pediatr Infect Dis J (1995) 0.97
Olecranon septic bursitis managed in an ambulatory setting. The Calgary Home Parenteral Therapy Program Study Group. Clin Invest Med (2001) 0.96
Prevalence of non-cavitated and cavitated carious lesions in a random sample of 7-9-year-old schoolchildren in Montreal, Quebec. Community Dent Oral Epidemiol (1992) 0.95
Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up. Can J Gastroenterol (1996) 0.95
Disseminated bacille Calmette-Guérin infection in an infant with a novel deletion in the interferon-gamma receptor gene. Int J Tuberc Lung Dis (2000) 0.93
Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine (2012) 0.93
Clinical and microbiologic features of children presenting with pertussis to a Canadian pediatric hospital during an eleven-year period. Pediatr Infect Dis J (1994) 0.93
Varicella zoster virus infections in Canadian children in the prevaccine era: A hospital-based study. Can J Infect Dis (1997) 0.93
Effect of inactivated poliovirus vaccine on the antibody response to Bordetella pertussis antigens when combined with diphtheria-pertussis-tetanus vaccine. Clin Infect Dis (1996) 0.92
Gender differences in the presentation, treatment, and short-term mortality of acute chest pain. Clin Invest Med (1994) 0.92
A swimming pool-associated outbreak of Cryptosporidiosis in British Columbia. Can J Public Health (1994) 0.89
Ten-year trends of heart disease risk factors in the Halifax County MONICA population. MONItoring of trends and determinants in CArdiovascular disease. Can J Cardiol (1998) 0.88
The role of exposures to animals and other risk factors in sporadic, non-typhoidal Salmonella infections in Michigan children. Zoonoses Public Health (2010) 0.88
Giardiasis outbreak from a chlorinated community water supply. Can J Public Health (1991) 0.88
Lung cancer in women. Thorax (1969) 0.88
A giant sigmoid diverticulum presenting as an upper abdominal mass. Ir J Med Sci (2007) 0.87
Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine (2007) 0.86
Epidemiology and outcome of osteomyelitis in the era of sequential intravenous-oral therapy. Pediatr Infect Dis J (1998) 0.85
Effects of hyperventilation on pattern-reversal visual evoked potentials in patients with demyelination. J Neurol Neurosurg Psychiatry (1986) 0.85
An observational study of sexual behavior in demented male patients. J Gerontol A Biol Sci Med Sci (1996) 0.85
Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. Pediatr Infect Dis J (2000) 0.85
Evaluation of potential factors contributing to microbiological treatment failure in Streptococcus pyogenes pharyngitis. Can J Infect Dis (2001) 0.84
Comparison of parental and health care professional preferences for the acellular or whole cell pertussis vaccine. Pediatr Infect Dis J (1998) 0.84
The incidence and correlates of erectile problems in patients with Alzheimer's disease. Arch Sex Behav (1990) 0.84
Candida infection in pediatric liver transplant recipients. Liver Transpl Surg (1999) 0.83
Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? CMAJ (1993) 0.83
Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children. Vaccine (1995) 0.83
Neural correlates of implicit object identification. Neuropsychologia (2004) 0.83
Clinical, morphological, and biochemical alterations in acute intestinal Yersiniosis. Pediatr Res (1986) 0.82
Evaluation of the Strep A OIA assay versus culture methods: ability to detect different quantities of group A Streptococcus. Diagn Microbiol Infect Dis (1999) 0.82
Trends in the incidence of acute myocardial infarction between 1984 and 1993 - The Halifax County MONICA Project. Can J Cardiol (2000) 0.82
Local adverse reactions to adsorbed DPT vaccine--Surrey, British Columbia. Can Dis Wkly Rep (1989) 0.82
Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria. Clin Exp Immunol (1991) 0.81
Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants. Vaccine (1999) 0.81
Predictors and outcome of admission for invasive Streptococcus pneumoniae infections at a Canadian children's hospital. Clin Infect Dis (1998) 0.81
Alzheimer's disease: beta-amyloid precursor protein mRNA expression in mononuclear blood cells. Neurosci Lett (1991) 0.81
Cerebral potentials accompanying visually triggered finger movement in man. Electroencephalogr Clin Neurophysiol (1985) 0.81
Post-marketing surveillance of adverse events following ProHIBit vaccine--British Columbia. Can Dis Wkly Rep (1989) 0.80
Source derivation: application to topographic mapping of visual evoked potentials. Electroencephalogr Clin Neurophysiol (1984) 0.80
Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age. Pediatr Infect Dis J (1999) 0.80
Associations between repetitive questioning, resistance to change, temper outbursts and anxiety in Prader-Willi and Fragile-X syndromes. J Intellect Disabil Res (2008) 0.80
Mixed glandular and squamous-cell carcinoma of the bronchus. Thorax (1967) 0.80
Breastfeeding and antibody responses to routine vaccination in infants. Lancet (1992) 0.79
Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life. Vaccine (1996) 0.79
[Quality evaluation of primary health care in an urban area of southern Brazil]. Rev Saude Publica (1994) 0.78
Effects of a nursing-home respite admission on veterans with advanced dementia. Gerontologist (1993) 0.78
Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris. J Dermatolog Treat (2002) 0.78